{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:10:33Z","timestamp":1790939433981,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1124\/jpet.102.042788","type":"journal-article","created":{"date-parts":[[2003,1,21]],"date-time":"2003-01-21T19:25:12Z","timestamp":1043177112000},"page":"874-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["The Corticotropin-Releasing Factor1 Receptor Antagonist R121919 Attenuates the Behavioral and Endocrine Responses to Stress"],"prefix":"10.1016","volume":"304","author":[{"given":"David A.","family":"Gutman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly H.","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.V.","family":"Thrivikraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Nemeroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.042788_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1600001","article-title":"The role of corticotropin-releasing factor in depression and anxiety disorders.","volume":"160","author":"Arborelius","year":"1999","journal-title":"J Endocrinol"},{"key":"10.1124\/jpet.102.042788_bib2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0022-3565(24)39110-4","article-title":"Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.","volume":"294","author":"Arborelius","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.042788_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/74263","article-title":"Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.","volume":"24","author":"Bale","year":"2000","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.102.042788_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0018-506X(87)90023-7","article-title":"A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice.","volume":"21","author":"Berridge","year":"1987","journal-title":"Horm Behav"},{"key":"10.1124\/jpet.102.042788_bib5","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1523\/JNEUROSCI.09-10-03513.1989","article-title":"Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF.","volume":"9","author":"Berridge","year":"1989","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.102.042788_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0165-6147(96)81594-X","article-title":"Corticotrophin-releasing factor receptors: from molecular biology to drug design.","volume":"17","author":"Chalmers","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.102.042788_bib7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0896-6273(93)90230-O","article-title":"Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.","volume":"11","author":"Chang","year":"1993","journal-title":"Neuron"},{"key":"10.1124\/jpet.102.042788_bib8","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1021\/jm960149e","article-title":"Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists.","volume":"39","author":"Chen","year":"1996","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.102.042788_bib9","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.1073\/pnas.90.19.8967","article-title":"Expression cloning of a human corticotropin-releasing-factor receptor.","volume":"90","author":"Chen","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.042788_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(90)90646-S","article-title":"Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization.","volume":"512","author":"Cole","year":"1990","journal-title":"Brain Res"},{"key":"10.1124\/jpet.102.042788_bib11","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1523\/JNEUROSCI.05-12-03189.1985","article-title":"Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study.","volume":"5","author":"De Souza","year":"1985","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.102.042788_bib12","doi-asserted-by":"crossref","unstructured":"Grigoriadis DE, Chen C, Wilcoxen K, Chen T, Lorang MT, Bozigian H, Liu XJ, Ling N, McCarthy JR, DeSouze EB, et al. In vitro characterization of R121919: a novel non-peptide corticotropin-releasing factor 1 receptor antagonist for the potential treatment of depression and anxiety-related disorders Society for Neuroscience, 2000). New Orleans, LA.","DOI":"10.1016\/S0306-4530(00)90092-1"},{"key":"10.1124\/jpet.102.042788_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1996.tb15112.x","article-title":"Characterization of corticotropin-releasing factor receptor subtypes.","volume":"780","author":"Grigoriadis","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/jpet.102.042788_bib14","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1073\/pnas.97.11.6079","article-title":"Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine and autonomic responses to stress in primates.","volume":"97","author":"Habib","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.042788_bib15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jama.284.5.592","article-title":"Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood.","volume":"284","author":"Heim","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1124\/jpet.102.042788_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0893-133X(02)00299-3","article-title":"Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist.","volume":"27","author":"Heinrichs","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.102.042788_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-0115(97)01005-7","article-title":"Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior.","volume":"71","author":"Heinrichs","year":"1997","journal-title":"Regul Pept"},{"key":"10.1124\/jpet.102.042788_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-3956(98)90056-5","article-title":"The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.","volume":"33","author":"Holsboer","year":"1999","journal-title":"J Psychiat Res"},{"key":"10.1124\/jpet.102.042788_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.0953-816X.2000.01383.x","article-title":"The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats.","volume":"13","author":"Keck","year":"2001","journal-title":"Eur J Neurosc"},{"key":"10.1124\/jpet.102.042788_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/74271","article-title":"Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.","volume":"24","author":"Kishimoto","year":"2000","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.102.042788_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0361-9230(86)90233-9","article-title":"CRF antagonist partially reverses CRF- and stress-induced effects on feeding.","volume":"17","author":"Krahn","year":"1986","journal-title":"Brain Res Bull"},{"key":"10.1124\/jpet.102.042788_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0079-6123(08)62132-9","article-title":"Long-term behavioral and neuroendocrine adaptations to adverse early experience.","volume":"122","author":"Ladd","year":"2000","journal-title":"Prog Brain Res"},{"key":"10.1124\/jpet.102.042788_bib23","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1073\/pnas.121165198","article-title":"Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.","volume":"98","author":"Lewis","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.042788_bib24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1073\/pnas.92.3.836","article-title":"Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain [published erratum appears in Proc Natl Acad Sci USA (1995) 92: 5759].","volume":"92","author":"Lovenberg","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.042788_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(97)00025-3","article-title":"Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.","volume":"323","author":"Mansbach","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.042788_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/138161280505230110095255","article-title":"Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.","volume":"5","author":"McCarthy","year":"1999","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.102.042788_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0893-133X(01)00244-5","article-title":"Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent.","volume":"25","author":"Millan","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.102.042788_bib28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(24)38220-5","article-title":"Receptor binding, behavioral and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.","volume":"289","author":"Okuyama","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.042788_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0031-6997(25)06673-6","article-title":"Physiology and pharmacology of corticotropin-releasing factor.","volume":"43","author":"Owens","year":"1991","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.102.042788_bib30","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1517\/13543784.8.11.1849","article-title":"Corticotropin-releasing factor antagonists in affective disorders.","volume":"8","author":"Owens","year":"1999","journal-title":"Opin Invest Drugs"},{"key":"10.1124\/jpet.102.042788_bib31","series-title":"The Rat Brain in Stereotaxic Coordinates.","author":"Paxinos","year":"1986"},{"key":"10.1124\/jpet.102.042788_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0893-133X(97)00071-7","article-title":"Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.","volume":"17","author":"Primus","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.102.042788_bib33","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1073\/pnas.93.19.10477","article-title":"CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.","volume":"93","author":"Schulz","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.042788_bib34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s002130050608","article-title":"CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats.","volume":"137","author":"Shaham","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.102.042788_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0304-3940(96)13254-7","article-title":"Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats.","volume":"220","author":"Smagin","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.102.042788_bib36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1037\/0735-7044.103.3.648","article-title":"Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats.","volume":"103","author":"Takahashi","year":"1989","journal-title":"Behav Neurosci"},{"key":"10.1124\/jpet.102.042788_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(00)02405-7","article-title":"Sensitivity to glucocorticoid-mediated fast-feedback regulation of the hypothalamic-pituitary-adrenal axis is dependent upon stressor specific neurocircuitry.","volume":"870","author":"Thrivikraman","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/jpet.102.042788_bib38","first-page":"E497","article-title":"Absence of glucocorticoid negative feedback to moderate hemorrhage in conscious rats.","volume":"264","author":"Thrivikraman","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.102.042788_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/520","article-title":"Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor [comments].","volume":"19","author":"Timpl","year":"1998","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.102.042788_bib40","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6267699","article-title":"Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and \u03b2-endorphin.","volume":"213","author":"Vale","year":"1981","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.102.042788_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U","article-title":"Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse.","volume":"428","author":"Van Pett","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1124\/jpet.102.042788_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3956(00)00016-9","article-title":"Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated.","volume":"34","author":"Zobel","year":"2000","journal-title":"J Psychiat Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524361816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524361816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.042788","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:38:41Z","timestamp":1739990321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524361816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S0022356524361816"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.042788","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.719110569.793505803","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Corticotropin-Releasing Factor1 Receptor Antagonist R121919 Attenuates the Behavioral and Endocrine Responses to Stress","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.042788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}